MétaCan
Menu
Back to cohort
Record W4414441409 · doi:10.1016/s0140-6736(25)01294-2

New landscape of the diagnosis of Alzheimer's disease

2025· review· en· W4414441409 on OpenAlexaff
Giovanni B. Frisoni, Oskar Hansson, Emma Nichols, Valentina Garibotto, Suzanne E. Schindler, Wiesje M. van der Flier, Frank Jessen, Nicolas Villain, Eider M. Arenaza‐Urquijo, Lucía Crivelli, Juan Fortea, Lea T. Grinberg, Zahinoor Ismail, Satoshi Minoshima, Rik Ossenkoppele, Henrik Zetterberg, Ronald Petersen, Bruno Dubois

Bibliographic record

VenueThe Lancet · 2025
Typereview
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsUniversity of Calgary
FundersUCB PharmaInstituto de Salud Carlos IIIGrifolsH. Lundbeck A/SBiogenAlzheimer NederlandStichting DioraphteHersenstichtingGeneralitat de CatalunyaUniversité de GenèveUniversità degli Studi di GenovaEisaiEuropean Brain CouncilDanoneEuropean CommissionMinisterio de Ciencia e InnovaciónNovo NordiskUniversity College LondonRoche NederlandHealth~HollandBrightFocus FoundationEli Lilly and CompanyAlzheimer's AssociationFONDATION ALZHEIMERZonMwNational Institutes of HealthUniversity of California
KeywordsDiseaseDifferential diagnosisDiagnostic testHealth careMEDLINEPatient careDifferential (mechanical device)

Abstract

fetched live from OpenAlex

Alzheimer's disease involves a drastic departure from the cognitive, functional, and behavioural trajectory of normal ageing, and is both a dreaded and highly prevalent cause of disability to individuals, and a leading source of health and social care expenditure for society. Before the advent of biomarkers, post-mortem examination was the only method available to establish a definitive diagnosis. In this first paper of the Series, we review state-of-the-art diagnostic practices and the typical patient journey in specialist settings, where clinicians engage in a differential diagnosis to establish whether Alzheimer's pathology (cerebral deposition of β-amyloid and hyperphosphorylated tau) is a contributor to cognitive impairment. Biomarkers indicating dysregulation of β-amyloid and tau homeostasis, measured with PET and cerebrospinal fluid analysis, allow a molecular-level diagnosis-a mandatory step in defining eligibility for the recently approved anti-amyloid treatments. We anticipate that easily accessible blood biomarkers, already available in some countries, will lead to a new diagnostic revolution and bring about major changes in health-care systems worldwide.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.004
Threshold uncertainty score0.017

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.004
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0030.003
Science and technology studies0.0000.002
Scholarly communication0.0020.004
Open science0.0010.001
Research integrity0.0020.005
Insufficient payload (model declined to judge)0.0040.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.072
GPT teacher head0.392
Teacher spread0.320 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations73
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueThe LancetSame topicDementia and Cognitive Impairment ResearchFrench-language works237,207